| Effect of antiepileptic drugs on bone density in ambulatory patients G Farhat, B Yamout, MA Mikati, S Demirjian, R Sawaya, ... Neurology 58 (9), 1348-1353, 2002 | 494 | 2002 |
| Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study B Yamout, R Hourani, H Salti, W Barada, T El-Hajj, A Al-Kutoubi, ... Journal of neuroimmunology 227 (1-2), 185-189, 2010 | 411 | 2010 |
| Narghile (hubble-bubble) smoking, low birth weight, and other pregnancy outcomes IA Nuwayhid, B Yamout, G Azar, MAK Kambris American journal of epidemiology 148 (4), 375-383, 1998 | 208 | 1998 |
| Predictors of quality of life among multiple sclerosis patients: a comprehensive analysis B Yamout, Z Issa, A Herlopian, M El Bejjani, A Khalifa, AS Ghadieh, ... European Journal of Neurology 20 (5), 756-764, 2013 | 169 | 2013 |
| Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone MA Mikati, L Dib, B Yamout, R Sawaya, AC Rahi, GEH Fuleihan Neurology 67 (11), 2005-2014, 2006 | 155 | 2006 |
| Predictors of bone density in ambulatory patients on antiepileptic drugs GEH Fuleihan, L Dib, B Yamout, R Sawaya, MA Mikati Bone 43 (1), 149-155, 2008 | 125 | 2008 |
| Extracranial venous stenosis is an unlikely cause of multiple sclerosis B Yamout, A Herlopian, Z Issa, RH Habib, A Fawaz, J Salame, A Wadih, ... Multiple Sclerosis Journal 16 (11), 1341-1348, 2010 | 106 | 2010 |
| Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis T Kalincik, EK Havrdova, D Horakova, G Izquierdo, A Prat, M Girard, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (4), 458-468, 2019 | 90 | 2019 |
| Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines B Yamout, M Sahraian, S Bohlega, M Al-Jumah, R Goueider, M Dahdaleh, ... Multiple sclerosis and related disorders 37, 101459, 2020 | 88 | 2020 |
| Risk of secondary progressive multiple sclerosis: a longitudinal study A Fambiatos, V Jokubaitis, D Horakova, E Kubala Havrdova, M Trojano, ... Multiple Sclerosis Journal 26 (1), 79-90, 2020 | 79 | 2020 |
| Prolactin secretion is increased in patients with multiple sclerosis ST Azar, B Yamout Endocrine research 25 (2), 207-214, 1999 | 66 | 1999 |
| Efficacy and safety of natalizumab extended interval dosing BI Yamout, MA Sahraian, N El Ayoubi, H Tamim, J Nicolas, SJ Khoury, ... Multiple sclerosis and related disorders 24, 113-116, 2018 | 65 | 2018 |
| Safety and efficacy of rituximab in multiple sclerosis: a retrospective observational study BI Yamout, NK El-Ayoubi, J Nicolas, Y El Kouzi, SJ Khoury, ... Journal of immunology research 2018, 2018 | 62 | 2018 |
| Pregnancy and the use of disease-modifying therapies in patients with multiple sclerosis: benefits versus risks R Alroughani, A Altintas, M Al Jumah, M Sahraian, I Alsharoqi, A AlTahan, ... Multiple sclerosis international 2016, 2016 | 60 | 2016 |
| Clinical characteristics of multiple sclerosis in Lebanon B Yamout, W Barada, RA Tohme, A Mehio-Sibai, R Khalifeh, T El-Hajj Journal of the neurological sciences 270 (1-2), 88-93, 2008 | 59 | 2008 |
| Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region BI Yamout, W Assaad, H Tamim, S Mrabet, R Goueider Multiple Sclerosis Journal–Experimental, Translational and Clinical 6 (1 …, 2020 | 58 | 2020 |
| Effect of vitamin D replacement on cognition in multiple sclerosis patients H Darwish, R Haddad, S Osman, S Ghassan, B Yamout, H Tamim, ... Scientific Reports 7 (1), 45926, 2017 | 57 | 2017 |
| MR imaging findings in autosomal recessive hereditary spastic paraplegia R Hourani, T El-Hajj, WH Barada, M Hourani, BI Yamout American journal of neuroradiology 30 (5), 936-940, 2009 | 54 | 2009 |
| Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial T Chitnis, B Banwell, L Kappos, DL Arnold, K Gücüyener, K Deiva, ... The Lancet Neurology 20 (12), 1001-1011, 2021 | 53 | 2021 |
| Natalizumab, fingolimod, and dimethyl fumarate use and pregnancy-related relapse and disability in women with multiple sclerosis WZ Yeh, PA Widyastuti, A Van der Walt, J Stankovich, E Havrdova, ... Neurology 96 (24), e2989-e3002, 2021 | 51 | 2021 |
